1. When rats were given a single oral dose ofthe lipid-soluble fungicide 4-(2-chlorophenylhydrazono)-3-methyl[4-14C]isoxazol-5-one ([14C]drazoxolon), about 75% of the label was excreted in the urine and 13% in the faeces in 96hr. An additional 7% of the radioactivity was recovered as 14CO2 in 48hr. 2. About 8% of the label was excreted by rats in the bile in 0-24hr. and an additional 6% was excreted by the same route in 24-48hr. 3. When dogs were given a single oral dose of [14C]-drazoxolon about 35% of the label was excreted in the urine and a similar amount was excreted in the faeces in 96hr. 4. The major metabolites in the urine of the rat and the dog were identified as 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid (dog, 14%), the corresponding ether glucosiduronic acid (dog, 12%; rat, 13%) and ester sulphate (rat, 65%). 5. When rats were given a single oral dose of 3-methyl-4-([U-140]phenylhydrazono)isoxazol-5-one about 75% of the label was excreted in the urine and 15% in the faeces in 96hr. The major metabolite in the urine was identified as the ester sulphate conjugate of 2-(4-hydroxyphenylhydrazono)-acetoacetic acid. 6. Reduction ofthe azo link was ofminor quantitative significance. 7. These results are discussed in their relation to species differences in the toxicity of these compounds.
4-([U-140]phenylhydrazono)isoxazol-5-one about 75% of the label was excreted in the urine and 15% in the faeces in 96hr. The major metabolite in the urine was identified as the ester sulphate conjugate of 2-(4-hydroxyphenylhydrazono)-acetoacetic acid. 6. Reduction ofthe azo link was ofminor quantitative significance. 7. These results are discussed in their relation to species differences in the toxicity of these compounds. 4 -(2-Chlorophenylhydrazono)-3-methylisoxazol-5-one (I; R =C1; also known as drazoxolon) is one of a series of lipid-soluble arylazoisoxazolones that are valuable for the control ofpowdery mildew and a number of seed and soil-borne diseases (Geoghegan, Summers & Turner, 1965; Geoghegan, 1967) . The acute oral toxicity of drazoxolon in rats (LD5o 125mg./kg.) is appreciably less than in dogs (LD5o 17mg./kg.) although in both species it evokes convulsant activity. In contrast, 3-methyl-4-(phenylhydrazono)isoxazol-5-one (I; R = H) is of low toxicity to rats (LD5o > 2g./kg.) and is, moreover, devoid of convulsant activity. This paper describes the metabolism ofdrazoxolon by rats and dogs and that of 3-methyl-4-(phenylhydrazono)isoxazol-5-one by rats; the toxicological implications of the results are discussed. This compound was obtained as a technical-grade sample from Plant Protection Ltd. It was purified by repeatedly washing with methanol at 50°until the residue showed the presence of only a single coloured component when chromatographed on thin-layer plates of silica gel in benzeneethanol (9: 1, v/v). Two recrystallizations from ethanol gave drazoxolon (m.p. 166°) as pale-yellow needles. 4-(2-Chloro-4-hydroxyphenylhydrazono)-3-methyli8oxazol-5-one and 4-(4-hydroxyphenylhydrazono)-3-methylisoxazol-5-one. These two compounds, m.p. 212°(from ethanol) (Found: C, H, (3) (4) (5) (6) N, ; C1o0HC1N303 requires C, 47-5; H, 3-2; N, 16-4%) and m.p. 232°(from ethanol) (Found: C, H, (4) (5) (6) (7) (8) (9) (10) (11) N,  C1oH9N303 requires C, 54-8; H, 4-10; N, 19-2%) respectively,werepreparedbythe general procedure of Summers, Freeman & Shields (1965) whereby an aqueous solution of NaNO2 was added to a cold mixture of ethyl acetoacetate, hydroxylamine and the appropriate aminophenol in HCl. After standing for 1-2hr. the precipitate was collected by filtration and recrystallized.
2 -(2 -Chloro-4-hydroxyphenylhydrazono)acetoacetic acid.
4-(2-Chloro-4-hydroxyphenylhydrazono)-3-methylisoxazol-5-one (1g.) was added to water (150ml.) and the suspension boiled vigorously for 18hr. The solution was then concentrated under reduced pressure at 400 and the residue recrystallized from aq. methanol to give yellow needles, m.p. 2210 (Found: C, 46-7; H, 3 6; N, 10-6; C1oH9C1N204 requires C, 46-7; H, 3-5; N, 10-9% , 3-8; N, 11-6; C1eHsClN203 requires C, 49-8; H, 3-7; N, 11-7%) . 4-Amino-3-chlorophenol, m.p. 1600, was prepared by the catalytic reduction of the corresponding nitro compound obtained as described by Hodgson & Moore (1925) .
1-8mc) and ethanol (0-5ml.) were added to Na2CO3 (175mg.) in water (2-5ml.) and the mixture was stirred at 0-5°while a solution of hydroxylamine hydrochloride (230mg.) in water (0-5ml.) was added over a period of 5min. Stirring was continued for 10min. and for an additional 20min. after the temperature of the reaction mixture had been raised to 200. The mixture was extracted with ether (4 x 2 ml.) and a solution of morpholine (265mg.) in ethanol (0-5ml.) added to the combined extracts. The ether was removed by evaporation, the residue heated at 650 for 10min. and the morpholine-isoxazolone complex precipitated with ether. The complex was dissolved in ethanol (1-5ml.), chilled and added to a freshly prepared solution of diazotized o-chloroaniline (282 mg. (specific-pathogen-free) . During the experiments the animals were kept in individual glass metabolism cages permitting the separate collection of urine and faeces. Unrestricted food and water were supplied, and the excreta were collected daily and stored at -200. When the expired air was analysed for 14CO2, air was drawn through the cages at 1 1./min. and passed through two traps in series containing 2M-NaOH.
The bile duct was cannulated in rats that had been previously given a solution of [14C]drazoxolon by stomach tube. After recovery from the anaesthetic they were placed in individual restraining cages and provided with water containing glucose (1%) and NaCl (0-9%). Bile was collected for either 24 or 48hr.
In experiments involving the isolation and characterization ofmetabolites in the urine, rats were given by stomach tube an aqueous suspension (5%, w/v) of unlabelled drazoxolon or 3-methyl-4-(phenylhyrazono)isoxazol-5-one. Groups of five animals were housed in metabolism cages and urine was collected for 24hr.
In experiments with dogs, adult beagle hounds (13-15 kg. body wt.) were given a gelatin capsule containing a solution of [14C]drazoxolon in polyethylene glycol 300. They were then transferred to individual metabolism cages and unrestricted food and water were allowed. Urine and faeces were collected daily and stored at -20°. The experiments were terminated 96hr. after dosage.
Details of the amount and radioactivity of the doses are given in the appropriate Tables.
Measurement of radioactivity. Liquid-scintillation counting of the biological samples and of subsequent fractions was made according to the methods described by Daniel & Gage (1965) , with a Packard Tri-Carb model 3002 liquid scintillation spectrometer (Packard Instrument Co. Ltd. Wembley, Middx.).
Measurement of spectra. Ultraviolet spectra of solutions of purified metabolites and of reference compounds in Spectrosil-grade methanol were measured with a Unicam SP.800 spectrophotometer. The i.r. spectra of materials dispersed in liquid paraffin were determined with a PerkinElmer 21 spectrometer. Mass spectra were obtained with an MS9 double-focussing spectrometer (Associated Electrical Industries Ltd., Manchester) and the n.m.r. spectra were determined with a Varian HA-100 spectrometer.
Chromatography. Fractions were chromatographed on thin-layer plates ofsilica gel G and developed with the solvent systems shown in Table 1 . The plates were then examined by radioautography with Ilford Industrial G X-ray film. Non-radioactive reference compounds and metabolites were either detected visually or by spraying successively with 2M-HCI, 1% (w/v) NaNO2 and aq. 1% (w/v) N-l-naphthylethylenediamine. Glucuronic acid conjugates were detected by spraying with a solution of 2% (w/v) naphtharesorcinol in 33% (w/v) trichloroacetic acid and heating the plate at 1350 for 5min. Areas of the support corresponding with radioactivity were scraped off the plate and transferred to a vial containing liquid scintillator. For the purification of metabolites before identification, a solution was applied as a band to a thin-layer plate and, after development, the radioactive area was located and removed. The radioactivity was extracted from the support with methanol and the chromatography repeated on a second plate, with a different solvent system if necessary.
Estimation of 4-amino-3-chlorophenol in urine. Sufficient conc. HCI was added to urine to give a solution molar with respect to the acid. The solution was heated at 1000 for 30min., cooled, adjusted to pH7 with m-NaOH and 696
1969 Table 1 . Rp values and absorption spectra of reference compounds Solvent mixtures (by vol.; upper phases): A, benzene-ethanol (9:1); B, di-isopropyl ether saturated with water; C, butan-l-ol saturated with water; D, butan-l-ol-acetic acid-water (4:1:5); E, butan-2-ol saturated with water.
Rp
Light-absorption in ethanol t Inflexion.
extracted twice with ethyl acetate (10-15ml.). Amino compounds in the combined extracts were extracted into m-HCl and 4-amino-3-chlorophenol was estimated colorimetrically after diazotization and coupling with N-1-naphthylpropylenediamine as described by Daniel (1961) . When the amine (100lg.) was added to normal urine (50ml.) the recovery was 98% (range 95-101% The rest of the urine was acidified (pH2) and extracted continuously with ether for 24hr. The ether was separated and extracted with 2M-NaHCO3 (25ml.). The aqueous phase was collected and extracted successively at pH4 and pH 2 with ethyl acetate. The extracts were separately concentrated under reduced pressure at 400 and the residues dissolved in a small volume of methanol. The urine remaining after extraction of all ether-soluble acidic metabolites was mixed with an equal volume of conc. HCl and the solution boiled vigorously under N2 for 2hr. The solution was then neutralized with Na2CO3 and extracted continuously with ether for 18 hr. The extract was separated, washed once with an equal volume of water and then extracted with 2M-HCI (20ml.). The aqueous phase was separated, neutralized with Na2CO3 and re-extracted by shaking with ether (50ml.). The ethereal solution was concentrated to low volume by blowing N2 over the surface of the solution. It was then applied as a band to a plate (20cm. x 20cm.) of silica gel and the chromatogram developed with solvent system B. The plate was partially covered, leaving a strip along one edge, which was sprayed to reveal amino compounds. The area of gel corresponding to the major component was removed and extracted with methanol.
(b) Rat bile. The 24hr. bile of two rats dosed with [14C]drazoxolon were combined and added to a column (2cm.x20cm.) of DEAE-cellulose (Clh form) (Whatman DE-11 grade). The column was eluted with a gradient of 0-05M-HCI into water (250ml.), 35 fractions (each 10ml.) being collected. The column was then eluted with 0-1 m-HCl, a further 15 fractions being collected. Fractions 21-27, containing the bulk of the radioactivity, were combined and extracted with butan-1-ol (50ml.). The extract was then concentrated and the residue redissolved in methanol (Iml.). The combined extracts were dried over anhydrous Na2SO4
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and concentrated under reduced pressure, and the residue was dissolved in methanol (lOml. l8olation of metabolites from urine of rats dosed with 3-methyl -4-(phenylhydrazono)i8oxazol-5-one. The urine samples (24hr.) of five rats dosed with 3-methyl-4-(phenylhydrazono)isoxazol-5-one (500mg./kg.) were combined and centrifuged. One portion was brought to pH5 by the addition of acetic acid, and a solution of saturated lead acetate (0-5vol.) was added. The precipitate was collected, washed twice with water and gassed with H2S. The PbS was removed by filtration and the filtrate concentrated under reduced pressure. A little methanol was added and the precipitate that formed was collected, washed with ether and air-dried.
The remaining urine was hydrolysed for 1 hr. with 2M-HCI, cooled and extracted continuously with ether. The ether was evaporated under reduced pressure and the residue recrystallized from aq. methanol.
RESULTS
Elimination of radioactivity by rate dosed with [14C]drazoxolon (Table 2) . After a single oral dose of [14C]drazoxolon rats excreted 73-6% (68-8-81-0%) of the label in the urine and 12-2% (9-2-15-4%) in the faeces. In three experiments 3-7% (2-7-5-3%) was excreted as 14CO2 in the expired gases in 24hr., and in two of these experiments an additional 1-6% and 1-8% was similarly excreted in 24-48hr. The total recovery of radioactivity in 96hr. was about 90% (81-102%).
The rate of elimination of radioactivity in the urine was somewhat variable: 41-0-74-2% of the 14C was excreted during 0-24hr. and 6-4-28-5% in 24-48hr. The low excretion of 14C in the faeces during the first 24hr. after dosage indicates almost complete alimentary absorption. The excretion of 14CO2 from [14C]drazoxolon during 24-48hr. suggests that a proportion of [14C]drazoxolon is only slowly metabolized. Only a small amount of radioactivity was excreted in bile: 8-3% (7-6-9-4%) in 0-24hr. and 6-3% (4-6-9-2%) during 24-48hr. (Table 3) . These values correlate well with the 14C excreted in the faeces in 24-48hr. and 48-72hr. (Table 2 ) respectively and suggest the absence of any significant reabsorption of metabolites excreted in the bile.
Elimination of radioactivity by doge dosed with [14C]drazoxolon (Table 4) . When [14C]drazoxolon was administered as a solution in polyethylene glycol 300 about 70% of the 14C was excreted in 96hr.
The amount of 14C excreted in the urine was about equal to that in the faeces. The low faecal excretion of label during 0-24hr. is presumptive evidence of almost quantitative alimentary absorption. The 14C that subsequently appeared in the faeces probably represented material excreted into the intestine, presumably in bile. In both experiments a similar amount of 14C was excreted in the urine on the first and second days. This could be due to intestinal reabsorption. If it is assumed that all 14C in the urine on the second day was so derived then it can be calculated that about 30% of the material excreted into the intestine was reabsorbed.
Elimination of radioactivity by rate dosed with 3 -methyl -4 -([U-14C]phenylhydrazono)i8oxazol -5 -one (Table 5) . A single dose of 3-methyl-4-([U-'4C]-phenylhydrazono)isoxazol-5-one was excreted by rats largely (73-4-84-8%) in the urine, the remainder (13-9-15-8%) being excreted in the faeces. Urinary excretion was rapid, 75% (66-6-77-9%) of the label being excreted during 0-24hr. and 5-1% (4-6-5-5%) material that was readily extracted into ethyl acetate at pH 5. Chromatography in solvent systems C, D and E showed this material to be identical with authentic 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid. There was no evidence for the formation of this material from the control enzyme digests. The metabolite was also isolated from the acid-hydrolysed urine of five rats dosed with unlabelled drazoxolon. The identity of the compound was established by n.m.r. spectroscopy and by comparing the i.r.-and u.v. -absorption spectra with that of the authentic material.
Continuous extraction of acidified urine with ether resulted in the recovery of 80-85% of the radioactivity as ether-soluble metabolites. Fractionation showed that most of the ether-soluble radioactivity was extractable into ethyl acetate at pH 4, and the remainder was extracted at pH 2. The pH4 extract contained a single metabolite, which was chromatographically identical with 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid. The pH2 extract contained two metabolites, RF 0-31 and 0-25 (solvent system C), corresponding to 4% and 16% of the radioactivity present in the urine. The component with RF 0-25 gave apositive reaction for glucuronide and was chromatographically identical with one of the major metabolites in dog urine, the nature of which is discussed below. The metabolite with Rp 0-31 has not been identified.
4-Amino-3-chlorophenol was detected on chromatograms, developed in solvent system B, of the ether Vol. 111J. W. DANIEL extract of acid-hydrolysed urine and its identity confirmed by a comparison of the u.v. spectrum with that of the authentic material. Quantitative analysis showed that about 7% of the drazoxolon administered was excreted as derivatives of 4-amino-3-chlorophenol.
(b) Rat bile. Fractions 21-27 contained radioactivity equivalent to 5% of the dose. Chromatography in solvent system D indicated the presence of two labelled compounds. The slower-moving component (RF 0.23) gave a positive reaction for a glucuronide (naphtharesorcinol) and was chromatographically indistinguishable from the glucuronide isolated from dog urine. About 20% of the activity in bile was due to this component. The second, faster-moving, component (RF 0-44) was readily hydrolysed on warming with dilute mineral acid to give an ether-soluble derivative identified chromatographically as 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid. Presumably this material was present in bile as a labile (e.g. sulphate) ester.
The ratio of glucuronide to sulphate in bile was 4:1, corresponding to a 5:1 ratio for the urine.
(c) Dog urine. The extraction of dog urine at pH6-5 with ether-ethanol removed 55% of the radioactivity, and the remainder was extracted at pH 2. Chromatography of the material extracted at pH 6-5 showed the presence of only one compound, which was shown to be identical with 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid by cochromatography with the authentic material in solvent systems C, D and E. The major radioactive fraction separated from the pH 2 extract by column chromatography also showed the presence of a single component, RF 0-21 in solvent system C. The material, which gave a positive reaction for a glucuronide, was quantitatively converted into 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid after incubation with fl-glucuronidase, whereas in control digests only the unhydrolysed starting material was recovered by extraction of the incubation medium at pH 2. The aglycone and the conjugate were both treated with 1 % sodium dithionite (1 ml.) and the solutions after adjustment to pH 7 were extracted with ethyl acetate. Chromatography of the extracts in solvent system C showed the presence of 4-amino-3-chlorophenol only in the extract obtained by reduction of the aglycone. This established the metabolite to be the ether glucuronide of 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid. Had it been an ester glucuronide, reduction of both the aglycone and the conjugate would have given the free aminophenol. The minor metabolite in extracts of rat urine (RF 0-25 in solvent C) has been tentatively assigned the same configuration because of similar chromatographic behaviour.
The quantitative excretion of metabolites of drazoxolon in rats and dogs is summarized in Table 6 .
Identification of metabolite8 of 3-methyl-4-(phenylhydrazono)i8oxazol-5-one in rat urine. Most (89%) of the radioactivity in the freeze-dried urine was recovered in the methanol extract. Chromatography ofthis solution in solvent system D indicated the presence of four radioactive metabolites with RF values 0-10 (6%), 0-38 (63%), 0-51 (7%) and 0-81 (8%); the values in parentheses represent the proportions of each metabolite. The material with Rp 0-38 was isolated by preparative thin-layer chromatography and a portion subjected to hydrolysis with arylsulphatase. Although less than 30% of the radioactivity could then be extracted into ether at pH5 from the control digest, about 83% was extracted from the test digest. Chromatography of this latter extract in solvent system D showed the presence of only a single radioactive compound, which appeared to be identical with the material with Rp 0-81 referred to above; co-chromatography with authentic 2-(4-hydroxyphenylhydrazono)acetoacetic acid in solvent systems C and D showed the two to be identical. Moreover, the material was identical with that isolated from acid-hydrolysed rat urine. The evidence suggested that the material with Rp 0-38 was a labile sulphate conjugate of 2-(4-hydroxyphenylhydrazono)acetoacetic acid. The compound isolated by lead salt precipitation (see the Methods section) gave a positive test for sulphate (turbidimetric) after acid hydrolysis and a positive reaction Table 6 . Quantitative excretion of metabolite8 of [14C] for sulphur (Lassaigne's test). Incubation with arylsulphatase gave the free acid (RF 0.81), the identity of which has been described. Gel-plate purification of the metabolite with RF 0-10 gave material that gave a positive reaction for glucuronic acid. Although not positively identified it is thought to be the ether glucuronide of 2-(4-hydroxyphenylhydrazono)acetoacetic acid. No attempt has been made to identify the component with RF 0.51, but it seems possible that it is a derivative of p-aminophenol, since the original urine, after hydrolysis with dilute mineral acid, gave a positive indophenol reaction. DISCUSSION Drazoxolon is rapidly and virtually completely absorbed from the gastrointestinal tract of both rats and dogs. The major proportion of the absorbed 14C is excreted by rats in 48hr., mainly through the kidneys (70-80%), with smaller amounts in faeces (5-10%) and in the expired air (5-7%). In contrast, the excretion of radioactivity by the dog appears to be somewhat slower, although it was not possible to estimate the amount of 14C excreted in the expired air. Moreover, in the dog the excreted label is partitioned equally between urine and faeces. The rate of excretion of 14C in the urine in the periods 0-24hr. and 24-48hr. in both rats and dogs suggests the presence either ofan enterohepatic circulation of metabolites or, alternatively, of the slow release ofdrazoxolon from tissues. The analysis of the bile of rats dosed with drazoxolon (Table 3) indicates that the second alternative is probably correct. Moreover, the faecal excretion of radioactivity by rats approximates to the biliary excretion, an observation that suggests that any enterohepatic circulation that may occur is small. The greater faecal excretion of 14C by dogs suggests that the biliary excretion in this species is appreciably greater than that observed in the rat.
As far as the author is aware the fate of the isoxazolone moiety has not previously been described. Formation of the keto acid presumably involves hydrolysis via the intermediate ketoxime or amino derivative. Hydroxylation may precede hydrolysis, as no evidence was obtained for the presence of2-(2-chlorophenylhydrazono)acetoacetic acid.
The major primary metabolite of drazoxolon in both species is 2-(2-chloro-4-hydroxyphenylhydrazono)acetoacetic acid. Whereas in the rat it is excreted in the urine as the corresponding sulphate ester (65%) and as the ether glucuronide (13%), in the dog there was evidence for the presence of only the glucuronide (12%) and of the free acid. The conditions used for fractionation of the dog urine appear to exclude the possibility that the free acid was an artifact resulting from the hydrolysis of a labile conjugate.
The species differences in the excretion of radioactivity are probably to be attributed to differences in metabolism. Although little is known of the various factors that determine the extent to which a foreign compound is excreted in the bile, Millburn, Smith & Williams (1967) have postulated that when a compound is excreted by this route in appreciable amounts (5-10%) it must possess a strong polar anionic group and a molecular weight of about 300. Conjugation appears to play an important role in this respect, for bile acids (Haslewood, 1955) , bilirubin (Klatskin, 1961) and thyroxine (Flock & Bollman, 1962) are excreted in the bile as conjugates. The greater faecal excretion of drazoxolon metabolites by the dog may be due to the preferential excretion in the bile of the O-glucuronide (mol.wt. 432.5) of the corresponding arylazoacetoacetic acid. Only a small proportion of the radioactivity in rat bile was due to this particular metabolite, the major metabolite being a labile conjugate, probably the corresponding sulphate ester (mol.wt. 335.5). However, few studies have been reported on species differences in biliary excretion, and factors additional to that of molecular weight may be involved.
The presence of 4-amino-3-chlorophenol in the urine of both rats and dogs dosed with drazoxolon and of p-aminophenol in the urine of rats dosed with 3-methyl-4-(phenylhydrazono)isoxazol-5-one is evidence of reductive fission of the azo link. In contrast with the behaviour of I-phenylazo-2-naphthol (Daniel, 1962 ) and 4-dimethylaminoazobenzene (Stevenson, Dobriner & Rhoads, 1942) , reduction of the arylazoisoxazolones is, however, only of minor importance. In this respect they resemble the lipid-soluble phenylazopyrazolones (Jones, Ryan & Wright, 1966) . Daniel (1969) has shown that drazoxolon is not reduced when incubated with rat liver microsomes under conditions that effect the reduction of many other azo compounds (Fouts, Kamm & Brodie, 1957; Manchon, Gradnauer & Lowy, 1964; Daniel, 1967) . There is, as yet, no explanation for the observed stability of drazoxolon. The amino compounds formed in vivo may be derived from those watersoluble metabolites excreted in the bile that are reduced by intestinal micro-organisms (Radomski & Mellinger, 1962) .
The metabolism of 3-methyl-4-(phenylhydrazono)isoxazol-5-one by the rat is qualitatively and quantitatively similar to that of drazoxolon, the major metabolite in the urine being the sulphate ester of 2-(4-hydroxyphenylhydrazono)acetoacetic acid. The substitution of a chlorine atom into 3-methyl-4-(phenylhydrazono)isoxazol-5-one does not seem to influence the types of metabolic change Vol. III 701 the compound undergoes, although it profoundly affects toxicity. In the rat drazoxolon does not inhibit the activity of brain L-glutamate 1-carboxy-lyase (EC 4.1.1.15), nor does it affect the concentration of y-aminobutyric acid, thought to act as an inhibitor of neurotransmission (J. W. Daniel, unpublished work) . The mode of action of drazoxolon therefore differs from that of arylhydrazides (Davison, 1956 ). 2 -(2 -Chloro -4 -hydroxyphenylhydrazono)acetoacetic acid produces convulsions when injected into rats. The enhanced toxicity of drazoxolon to dogs may be associated with the presence in the urine of the free acid. Conjugation may therefore be considered to be a true detoxication reaction.
